Calibrate Health, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Calibrate Health, Inc. - overview

Established

2020

Location

New York, NY, US

Primary Industry

Healthcare IT

About

Based in New York, US, and founded in 2020 by CEO Isabelle Kenyon, Calibrate Health, Inc. offers a weight loss program that users can participate in virtually. In August 2021, Calibrate Health raised USD 100 million in Series B funding from Founders Fund, Tiger Global Management, Forerunner Ventures, and Redesign Health. The company provides a digital metabolic health platform for chronic weight management.


Calibrate Health combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions. Users undergo a lab test first to check their health history and then are assigned a coach and a free app for tracking all activities. The company generates revenue by charging subscription fees which start at USD 129 per month or USD 1,550 per year for a one-year virtual program and USD 249 for a one-time assessment with a calibrate doctor. The company plans to use its Series B funding raised in August 2021 to expand its telehealth platform and build its enterprise business with Glucagon-like Peptide 1 (GLP) hormones.


Current Investors

Forerunner Ventures, Redesign Health, Founders Fund

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Conferencing Software

Website

www.joincalibrate.com

Verticals

HealthTech, Mobile Apps

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.